INSCRIPCIONES ABIERTAS - Formación en integración para facilitadores. Infórmate ahora


For inquiries regarding the utilization of ethnobotanicals, or in case you are experiencing an adverse situation or difficulty integrating and experience, please read this page. For inquiries regarding legal support , please read this page.

  • We don’t offer sessions of ayahuasca or iboga.
  • We don’t recommend centers or people who perform/do sessions.

    map mapa marcador ICEERS


    Carrer de Sepúlveda, 65 , Oficina 2, 08015 Barcelona España +34 931 88 20 99
    press media ICEERS prensa medios

    Our Publications

    We’re grateful to have some of the leading minds in science, policy, human rights, and psychology working together to design solutions that will transform society’s relationship to ethnobotanicals. Their insights are helping build a more just and sustainable future.

    Our experts are available for speaking engagements and interviews in several languages and locations.

    Press Releases

    Press Guidelines

    A guide to factual information and best practices for journalists who want to write truthfully about ethnobotanicals.

    Common Errors

    A guide to the most common mistakes when referring to ayahuasca.

    Our publications

    Global Mental Health:

    Ona G, Berrada A, Bouso JC (2021). Communalistic use of psychoactive plants as a bridge between traditional healing practices and Western medicine: A new path for the Global Mental Health movement. Transcultural Psychiatry. doi: 10.1177/13634615211038416.

    Bouso JC, Sánchez-Avilés C (2020). Traditional Healing Practices Involving Psychoactive Plants and the Global Mental Health Agenda: Opportunities, Pitfalls, and Challenges in the “Right to Science” Framework. Harvard Health Hum Rights. 22(1):145-150.


    Rodrigues LS, Rossi GN, Rocha JM, L Osório F, Bouso JC, Hallak JEC, Dos Santos RG. (2021).  Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies. Eur Arch Psychiatry Clin Neurosci. doi: 10.1007/s00406-021-01267-7. 

    Rocha JM, Rossi GN, de Lima Osório F, Bouso JC, de Oliveira Silveira G, Yonamine M, Campos AC, Bertozi G, Cecílio Hallak JE, Dos Santos RG. (2021). Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial. J Clin Psychopharmacol. 41(3):267-274.

    Gonzalez D, Cantillo J, Perez I, Carvalho M, Aronovich A, Farre M, Feilding A, Obiols JE, Bouso JC. (2021). The Shipibo Ceremonial Use of Ayahuasca to Promote Well-Being: An Observational Study. Front Pharmacol. 12:623923.

    Dos Santos RG, Osório FL, Rocha JM, Rossi GN, Bouso JC, Rodrigues LS, de Oliveira Silveira G, Yonamine M, Hallak JEC. (2021). Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial. J Clin Psychopharmacol. 41(5):540-550.

    Perkins D, Schubert V, Simonová H, Tófoli LF, Bouso JC, Horák M, Galvão-Coelho NL, Sarris J. (2021). Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey. Front Pharmacol. 12:623979.

    Perkins D, Opaleye ES, Simonova H, Bouso JC, Tófoli LF, GalvÃo-Coelho NL, Schubert V, Sarris J. (2021). Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross-sectional survey. Drug Alcohol Rev. doi: 10.1111/dar.13348. 

    Gómez-Sousa M, Jiménez-Garrido DF, Ona G, dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC (2021). Acute psychological adverse reactions in first-time ritual ayahuasca users: A prospective case series. Journal of Clinical Psychopharmacology. 41(2):163-171.

    Durante I, Dos Santos RG, Bouso JC, Hallak JE (2020). Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects. Braz J Psychiatry. doi: 10.1590/1516-4446-2020-0913.

    Jiménez-Garrido DF, Gómez-Sousa M, Ona G, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MA, Bouso JC (2020). Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination. Nature Scientific Reports. 10(1):4075.

    González D, Cantillo J, Pérez I, Farré M, Feilding A, Obiols JE, Bouso JC (2020). Therapeutic potential of ayahuasca in grief: a prospective, observational study. Psychopharmacology (Berl). 237(4):1171-1182.

    Dos Santos RG, Bouso JC (2019). Translational evidence for ayahuasca as an antidepressant: what’s next? Braz J Psychiatry. 41(4):275-276.

    Ona G, Kohek M, Massaguer T, Gomariz A, Jiménez DF, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC (2019). Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users. J Psychoactive Drugs. 51(2):135-145.

    Dos Santos RG, Osório FL, Crippa JAS, Bouso JC, Hallak JEC (2019). The therapeutic potential of ayahuasca and other serotonergic hallucinogens in the treatment of social anxiety. En: Osório FL y Donadon MF (Eds.): Social anxiety disorders. Recognition, diagnosis and management. New York: Nova Science Publishers.

    Franquesa A, Sainz-Cort A, Gandy S, Soler J, Alcázar-Córcoles MA, Bouso JC (2018). Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach. Psychiatry Res. 264:334-339.

    dos Santos RG, Enyart S, Bouso JC, Pares O, Hallak JEC (2018). Ayahuasca turned on my mind’s eye”: Enhanced visual imagery after ayahuasca intake in a man with “blind imagination” (aphantasia). Journal of Psychedelic Studies. 2(2):74-77.

    González D, Carvalho M, Cantillo J, Aixalá M, Farré M (2019). Potential Use of Ayahuasca in Grief Therapy. Omega (Westport). 79(3):260-285.

    dos Santos RG, Bouso JC, Hallak JEC (2017). Ayahuasca: what mental health professionals need to know. Archives of Clinical Psychiatry (São Paulo). 44(4): 203-109.

    Dos Santos RG, Bouso JC, Hallak JEC (2017). Ayahuasca intoxication. Med Clin (Barc). 149(10):461-462.

    Dos Santos RG, Bouso JC, Hallak JEC (2017). Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Ther Adv Psychopharmacol. 7(4):141 157.

    Bouso JC, Pedrero-Pérez EJ, Gandy S, Alcázar-Córcoles MA. 2017. The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Barrett & Griffiths (2016). Hum Psychopharmacol. 32(1).

    Bouso JC, Pedrero-Pérez EJ, Gandy S, Alcázar-Córcoles MA. (2016). Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens. Hum Psychopharmacol. 31(5):356-72.

    Dos Santos RG, Balthazar, F, Bouso JC, Hallak JE. (2016). The current state of Research on ayahuasca: a systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning and neuroimaging. Journal of Psychopharmacology. 30(12):1230-1247.

    Dos Santos RG, L Osório F, S Crippa JA, Bouso JC, Hallak JE (2016). Letter to the Editor. J Forensic Leg Med. 38:116-7.

    Bouso JC, Palhano-Fontes F, Rodríguez-Fornells A, Ribeiro S, Sanches R, Crippa JA, Hallak JE, de Araujo DB, Riba J (2015). Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans. Eur Neuropsychopharmacol. 25(4):483-92.

    Riba J, McIlhenny EH, Bouso JC, Barker SA (2014). Metabolism and urinary disposition of N,Ndimethyltryptamine after oral and smoked administration: a comparative study. Drug Test Anal. 7(5):401-6.

    Bouso JC, Riba J (2014): Ayahuasca and the Treatment of Drug Addiction. In: BC Labate, C Cavnar (Eds): The Therapeutic Use of Ayahuasca. Berlin: Springer. Pp: 95- 109.

    Fernández X, dos Santos R, Cutchet M, Fondevila S, González D, Alcázar MA, Riba J, Bouso JC, Fábregas JM (2014): Assessment of the Psychotherapeutic Effects of Ritual Ayahuasca Use on Drug Dependency: A Pilot Study. In: BC Labate, C Cavnar (Eds): The Therapeutic Use of Ayahuasca. Berlin: Springer. Pp: 183-196.

    Bouso JC, Fábregas JM, Antonijoan RM, Rodríguez-Fornells A, Riba J (2013): Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users. Psychopharmacology (Berl). 230(3):415-24.

    Labate B y Bouso JC (2013): Cura, cura cuerpecito: reflexiones sobre las posibilidades terapéuticas de la ayahuasca. En: B. Labate y JC. Bouso: Ayahuasca y salud. Barcelona: Los Libros de la Liebre de Marzo. Pp: 28-47.

    Bouso JC, Fábregas JM, Fondevila S, González D, Cutchet M, Fernández X, Alcázar-Córcoles MÁ, Gómez-Jarabo, G (2013): Efectos a largo plazo sobre la salud mental del consumo ritual de ayahuasca. En: B Labate y JC Bouso (Eds.): Ayahuasca y salud. Barcelona: Los Libros de la Liebre.

    Bouso JC, Fábregas JM, Antonijoan, R, Rodríguez-Fornels, A, Riba J (2013): Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users. Psychopharmacology. 230(3): 415-24.

    Bouso JC, González D, Fondevila S, Cutchet M, Fernández X, Ribeiro Barbosa PC, Alcázar-Córcoles MA, Araújo WS, Barbanoj MJ, Fábregas JM, Riba J. (2012): Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study. PLoS One. 7(8):e42421.


    Ona G, Rocha JM, Bouso JC, Hallak JEC, Borràs T, Colomina MT, Dos Santos RG. (2021). The adverse events of ibogaine in humans: an updated systematic review of the literature (2015-2020). Psychopharmacology (Berl). doi: 10.1007/s00213-021-05964-y. 

    Faura R, Langlois A, Bouso JCB (2020). Expanding Ancestral Knowledge Beyond the Sale of Molecules: Iboga and Ibogaine in the Context of Psychedelic Commercialization. MAPS Bulletin. 30(19): 42-44.

    Bouso JC, Fornís I, Ventura-Vilamala M, De Loenen B, Sainz-Cort A, Jiménez-Garrido DF, dos Santos RG, Hallak JEC, Alcázar-Córcoles MA, Jenks CW (2020). An analytical study of iboga alkaloids contained in Tabernanthe iboga-derived products offered by ibogaine treatment providers. Archives of Clinical Psychiatry. 46(2):51-4.

    Kohek M, Ohren M, Hornby P, Bouso JCarlos (2020). The Ibogaine Experience: A Qualitative Study on the Acute Subjective Effects of Ibogaine. Anthropology of Consciousness. 31(1):91-119.

    Wilkins C, Dos Santos RG, Solá J, Aixalá M, Cura P, Moreno E, Alcázar-Córcoles MA, Hallak HEC, Bouso JC (2017). Detoxification from methadone using low, repeated, and increasing doses of ibogaine: A case report. Journal of Psychedelic Studies. 1(1): 29-34.

    Dos Santos RG, Bouso JC, Hallak JEC (2017). The antiaddictive effects of ibogaine: A systematic literatura review of human studies. Journal of Psychedelic Studies. 1(1):20-28.

    De Loenen B, Cura P, Bouso JC, Parés O (2013): El trabajo entre iguales en el desarrollo de la ibogaína como herramienta terapéutica en las adicciones. In: Llort Suárez A, Borràs Cabacés T: Apuntes para la promoción de intervenciones con pares. Reducción de daños y riesgos relacionados con el uso de drogas. Barcelona: Grup Igia. Pp: 282-303.


    Révész D, Ona G, Rossi GN, Rocha JM, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC. (2021). Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study. Front Psychiatry. 12:687546.

    Dos Santos RG, Bouso JC, Rocha JM, Rossi GN, Hallak JE. (2021). The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges. Risk Manag Healthc Policy. 5;14:901-910.

    Bouso JC, Ona G, Dos Santos RG, JEC Hallak (2021). Psychedelic Medicines in Major Depression: Progress and Future Challenges. Adv Exp Med Biol. 2021;1305:515-533.

    Ona G, Bouso JC. (2020). Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review. Neurosci Biobehav Rev. 119:194-203.

    Dos Santos RG, Bouso JC, Hallak JE (2020). Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy. Braz J Psychiatry. S1516-44462020005015210.

    Aixalá M, Ona G, Parés O, Bouso JC (2020). Patterns of use, desired effects, and mental health status of a sample of natural psychoactive drug users. Drugs: Education, Prevention and Policy. 27(3):191-198.

    Ona G, Bouso JC (2020). Psychedelic drugs as a long-needed innovation in psychiatry. Qeios. DOI: 10.32388/T3EM5E.2.

    Ona G, Bouso JC (2019). Can Psychedelics be the Treatment for the Crisis in Psychopharmacology? Preprints:

    Rocha JM, Osório FL, Crippa JAS, Bouso JC, Rossi GN, Hallak JEC, Dos Santos RG (2019). Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature. Ther Adv Psychopharmacol. 9:2045125319845774.

    Dos Santos RG, Bouso JC, Hallak JEC (2019). Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer. BMC Psychiatry. 19(1):321.

    Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC (2018). Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Rev Clin Pharmacol. Sep;11(9):889-902.

    Aixalà M, Dos Santos RG, Hallak JEC, Bouso JC (2018). Psychedelics and Personality. ACS Chem Neurosci. 9(10):2304-2306.

    Bouso JC, Dos Santos RG, Alcázar-Córcoles MÁ, Hallak JEC (2018). Serotonergic psychedelics and personality: A systematic review of contemporary research. Neurosci Biobehav Rev. 87:118-132.

    Jimenez-Garrido DF, Alcazar-Córcoles MA, Bouso JC (2015). Experiencias Cercanas a la Muerte y Sintomatología Postraumática en una Muestra de Consumidores de Ketamina. Journal of Transpersonal Research. 7(1):32-53.

    Bouso JC (2013): Alucinógenos etnobotánicos. En: DP Martínez Oró, J Pallarés Gómez (Eds.): De placeres y riesgos. Manual para entender las drogas. Lleida: Milenio.

    Bouso JC, Farré M (2013): Neurobiología de la psilocibina y potencialidades terapéuticas”. En: JC Bouso (Ed.): Psilocibes. Madrid: Ultrarradio/ICEERS. Pp: 44-67.


    Ona G, Bouso JC. (2021). Towards the Use of Whole Natural Products in Psychedelic Research and Therapy: Synergy, Multi-Target Profiles, and Beyond. Frontiers in Natural Product Chemistry. 8: 99-145.

    Ona GS, Dos Santos RG, Hallak JEC, Bouso JC (2020). Polypharmacology or “Pharmacological Promiscuity” In Psychedelic Research: What Are We Missing? ACS Chem Neurosci. 11(20):3191-3193.

    Oña G, Bouso JC (2021). Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology. Curr Med Chem. 28(1):53-68.


    Sainz-Cort A, Jimenez-Garrido D, Muñoz-Marron E, Viejo-Sobera R, Heeroma J, Bouso JC. (2021). Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study. J Clin Psychopharmacol. 41(5):561-570.

    Obradors-Pineda A, Bouso JC, Parés-Franquero Ò, Romaní JO. (2021). Harm reduction and cannabis social clubs: Exploring their true potential. Int J Drug Policy. doi: 10.1016/j.drugpo.2021.103358.

    Ona G, Balant M, Bouso JC, Gras A, Vallès J, Vitales D, Garnatje T. (2021). The Use of Cannabis sativa L. for Pest Control: From the Ethnobotanical Knowledge to a Systematic Review of Experimental Studies. Cannabis Cannabinoid Res. doi: 10.1089/can.2021.0095.

    Kohek M, Sánchez Avilés C, Romaní O, Bouso JC. (2021). Ancient psychoactive plants in a global village: The ritual use of cannabis in a self-managed community in Catalonia. Int J Drug Policy. doi: 10.1016/j.drugpo.2021.103390.

    Jiménez-Vinaja R, Imbernón M, Parés-Bayerri A, Onab G, Parés O,  Bouso JC (2021). Jailhouse rock: Health status, patterns of use, and associated benefits of cannabis use in a sample of inmates in Spanish prisons. Revista Española de Sanidad Penitenciaria (accepted).

    Jiménez-Garrido DF, Onaa G, Cura P, Parès A, Bismara-Paranhos BAP, Mendes FA, Yonamine M, dos Santos RG, Hallak JEC, Alcázar-Córcoles MA, Bouso JC (2021). Evaluación del estado de salud, patrones de consume y beneficios subjetivos del cannabis medicinal en una muestra de pacientes con enfermedad crónica. Salud Colectiva (under revission).

    Bouso JC, Jiménez-Garrido D, Ona G, Woźnica D, Dos Santos RG, Hallak JEC, Paranhos BAPB, de Almeida Mendes F, Yonamine M, Alcázar-Córcoles MÁ, Farré M. 2020. Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12- Month Longitudinal Study. Phytotherapy Research. 34(7):1670-1677.

    Rossi GN, Osório FL, Morgan CJA, Crippa JAS, Bouso JC, Rocha JM, Zuardi AW, Hallak JEC, Santos RGD (2020). The effects of Cannabidiol (CBD) and Delta-9 Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: A systematic review of randomized controlled trials. Neurosci Biobehav Rev. 118:236-246.

    Sanchéz-Avilés C (2020). The challenges of drug policy harmonization in the European Union: Cannabis policy innovations and the prospects for an ‘EU one voice’ in drug policy. American J of Intl Law, AJIL Unbound on Drug Decriminalization, Legalization and International Law, Vol 114, October 2020.

    Pardal M, Decorte T, Bone M, Parés O, Johansson J (2020). Mapping Cannabis Social Clubs in Europe. European Journal of Criminology. DOI:

    Parda M, Bone M, Decorte T, Queirolo R, Parés O, Johansson J, Álvarez R, Repetto L (2020). Hidden and uninterested populations: Methodological insights and unresolved issues from the study of Cannabis Social Clubs. Methodological Innovations. DOI: 10.1177/2059799120976963

    Arana, X., Parés, Ò. (2020). “Cannabis social clubs in Spain: Recent legal developments” a “Legalizing Cannabis Experiences, Lessons and Scenarios”. Editat per Tom Decorte, Simon Lenton, Chris Wilkins. Series: Routledge Studies in Crime and Society.

    Parés-Franquero O, Jubert-Cortiella X, Olivares-Gálvez S, Díaz-Castellano A, Jiménez-Garrido DF, Bouso JC (2019). Use and Habits of the Protagonists of the Story: Cannabis Social Clubs in Barcelona. Journal of Drug Issues. 49(4):1-18.

    Bouso JC, dos Santos RG, JEC Hallak (2019). Potential Applications of Cannabis and Cannabinoids in the Treatment of Substance Use Disorder and in Harm Reduction. In: M.J. Winkelman, B.S. (Editor): Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications. NY: ABC-CLIO, Incorporated, Pp: 148-169.

    Jansseune L, Pardal M, Decorte T, Parés-Franquero O (2018). Revisiting the Birthplace of the Cannabis Social Club Model and the Role Played by Cannabis Social Club Federations. Journal of Drug Issues. 49(2):338-354.

    Parés O. (2018) Epifanía cannábica, segundo y tercer movimiento, allegro ma non troppo. Barcelona 2010-14. Drogas, desafios contemporaneos. SHECARIA, Segio Salomao; ARANA, Xabier; CARDOSO, Franciele Silva; MIRANDA, Bartira Madeco de; — Belo Horizonte: Editora D’Plácido.

    Bouso JC, Parés O (2017): Contextualización de los efectos socio-sanitarios del consumo de cannabis en España. En: VVAA: Cannabis: Un nuevo modelo de regulación. Manresa: Ediciones Bellaterra.

    Decorte T, Pardal M, Queirolo R, Boidi MF, Sánchez Avilés C, Parés Franquero O (2017). Regulating Cannabis Social Clubs: A comparative analysis of legal and self-regulatory practices in Spain, Belgium and Uruguay. Int J Drug Policy. 43:44-56.

    García de Palau M, Bouso JC (2017). Desarrollo de programas de cannabis medicinal. Riesgos asociados a los tratamientos con cannabis. En: JR Atance (Coord): Efectos terapéuticos de los cannabinoides. Madrid: Instituto universitario de Investigación en Neuroquímica de la Universidad Complutense de Madrid. Pp: 219-234.

    Bouso JC (2017). Sistema endocannabinoide y Farmacología del cannabis. En D. P. Martínez Oró (Coord.): Las sendas de la regulación del cannabis en España. Manresa: Ediciones Bellaterra. Pp: 193-207.

    Sanchéz-Avilés C (2017). El cannabis en las convenciones internacionales sobre drogas. Posibilidades y Desafíos para una regulación. En D. P. Martínez Oró (Coord.): Las sendas de la regulación del cannabis en España. Manresa: Ediciones Bellaterra. Pp. 259-273. 

    (2016) Cannabis Social Club. una política para el siglo XXI. FAAAT. Contribuciones y revisión.

    Drug Policy:

    Sanchéz-Avilés C, Ditrych O (2020). The evolution of international drug control under the United Nations. In:  C. Hallam, D. R. Bewley-Taylor & K. Tinasti (Ed.). Research Handbook on International Drug Policy. Cheltenham: Edward Elgar.

    Sanchéz-Avilés C (2020). Recientes desarrollos en la política internacional de drogas. Reflexiones en torno a la 63ª sesión de la Comisión de Estupefacientes de las Naciones Unidas. En: E. Conde (Coord). Ensayos para un nuevo paradigma en la política de drogas. ICEI Occasional Papers.

    Sanchéz-Avilés C, Ditrych O (2019). The International Drug Prohibition Regime as Security Regulation: Stability and Change in an Increasingly Less Prohibitionist World”. In Hynek, N., Ditrych, O., Stritecky, V. (Eds.): Regulating Global Security. Insights from Conventional and Unconventional Regimes. Londres: Palgrave Macmillan, pp. 215-243.

    Sanchéz-Avilés C, Ditrych O (2018). The global drug prohibition regime: prospects for stability and change in an increasingly less prohibitionist world. International Politics. 55:463–481.

    Bouso JC (2014): El sesgo legal en el estudio neuropsicológico de la adicción. In: JM Ruiz Sánchez de León, E Pedrero (Eds): Neuropsicología de la adicción. Madrid: Panamericana. Pp: 183-186.

    Technical Reports:

    Bouso JC (2021). Informe sobre el CBD (cannabidiol). (está en 4 idiomas)

    Bouso JC (Coord) (2013; 2017; 2021). Ayahuasca technical report. ICEERS.

    Bouso JC (Coord) (2020). La ayahuasca en España. Una evaluación de las personas participantes en ceremonias de ayahuasca utilizando indicadores de salud pública. ICEERS.

    Aixalá M, Bouso JC (2018). Technical Report on Psychoactive Plants.

    Sanchez-Avilés C, Collins M (2018). Better to Ask Forgiveness Than Permission: Spain’s Sub-national Approach to Drug Policy, Policy Brief 12, Swansea: Global Drug Policy Observatory / Barcelona: ICEERS.

    Sánchez-Avilés C, Bouso JC (2015). Ayahuasca: From the Amazon to the Global Village. An analysis of the challenges associated with the globalisation of ayahuasca. TIN: Drug Policy Briefings.

    Parés O y Bouso JC (2015): Hacer de la necesidad virtud. Políticas de drogas en Cataluña, de la acción local hacia el cambio global. Open Society Foundations: Serie lecciones en políticas de drogas.


    Bouso JC (2019). Cannabis medicinal. De droga prohibida a solución terapéutica. Barcelona: Amat Editores.

    Hofmann A (2018): LSD. Cómo descubrí el ácido y lo que pasó después en el mundo. Introducción, notas y epílogo de J.C. Bouso. Barcelona: Arpa.

    Sanchez-Avilés C (2017). El control de drogas. Normas internacionales, desafíos nacionales. El caso de la política de drogas en España. Valencia: Tirant lo Blanc.

    Peyraube R, Bouso JC (2015). ¿Marihuana como medicina? Usos médicos y terapéuticos del cannabis y los cannabinoides. Mexico: Transform.

    Bouso JC (Ed) (2013): Psilocibes. Madrid: Ultrarradio/ICEERS.

    Labate B, Bouso JC (Eds.) (2013). Ayahuasca y salud. Barcelona: Los Libros de la Liebre de Marzo.

    Cannabis regulation proposals:

    Ley de Regulación de la Producción, Distribución y Consumo de Cannabis. Grupo parlamentario PODEMOS.

    Grupo de Estudios en Políticas del Cannabis GEPCA (2017): Cannabis. Propuesta de un nuevo modelo de regulación.


    Londoño D, Mazarasa J, Aixalá M (2019). Hacia mejores prácticas en el uso de la ayahuasca. Una guía para quien organiza y participa. ICEERS / Agència de Salut Pública de Catalunya, Generalitat de Catalunya.